Goldman Sachs’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-22,933
| Closed | -$590K | – | 5403 |
|
|
2025
Q1 | $590K | Sell |
22,933
-26,853
| -54% | -$690K | ﹤0.01% | 4166 |
|
|
2024
Q4 | $1.44M | Buy |
49,786
+16,732
| +51% | +$483K | ﹤0.01% | 3697 |
|
|
2024
Q3 | $785K | Buy |
33,054
+19,831
| +150% | +$471K | ﹤0.01% | 3892 |
|
|
2024
Q2 | $229K | Buy |
+13,223
| New | +$229K | ﹤0.01% | 4310 |
|
|
2024
Q1 | – | Sell |
-4,077
| Closed | -$74.8K | – | 4956 |
|
|
2023
Q4 | $74.8K | Sell |
4,077
-749
| -16% | -$13.7K | ﹤0.01% | 4503 |
|
|
2023
Q3 | $83.8K | Sell |
4,826
-127
| -3% | -$2.21K | ﹤0.01% | 4416 |
|
|
2023
Q2 | $90.2K | Buy |
4,953
+3,070
| +163% | +$55.9K | ﹤0.01% | 4583 |
|
|
2023
Q1 | $32.3K | Sell |
1,883
-2,203
| -54% | -$37.8K | ﹤0.01% | 4829 |
|
|
2022
Q4 | $95K | Sell |
4,086
-31,876
| -89% | -$741K | ﹤0.01% | 4684 |
|
|
2022
Q3 | $798K | Sell |
35,962
-23,764
| -40% | -$527K | ﹤0.01% | 3969 |
|
|
2022
Q2 | $1.15M | Buy |
59,726
+54,399
| +1,021% | +$1.05M | ﹤0.01% | 3848 |
|
|
2022
Q1 | $190K | Buy |
5,327
+2,485
| +87% | +$88.6K | ﹤0.01% | 5119 |
|
|
2021
Q4 | $247K | Sell |
2,842
-7,745
| -73% | -$673K | ﹤0.01% | 4881 |
|
|
2021
Q3 | $1.22M | Sell |
10,587
-28,617
| -73% | -$3.28M | ﹤0.01% | 3842 |
|
|
2021
Q2 | $8.43M | Buy |
+39,204
| New | +$8.43M | ﹤0.01% | 2383 |
|